Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy-Reference-Cited by-同舟云学术

Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy

Published:2023-09-14 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Henault David¹²,Stephen David³,St-Hilaire Pierre-Antoine²,Messaoudi Nouredin²⁴,Vandenbroucke-Menu Franck¹,Simoneau Eve¹,Rong Zhixia¹,Plasse Marylène¹,Létourneau Richard¹,Roy André¹,Dagenais Michel¹,Lapointe Réal¹,Nguyen Bich³,Mes-Masson Anne-Marie²⁵,Soucy G.³,Turcotte Simon¹²^ORCID

Affiliation:

1. Hepato-Pancreato-Biliary Surgery Service, Centre hospitalier de l’Université de Montréal, Montréal, Québec, Canada

2. Cancer Axis, Centre de recherche du Centre Hospitalier de l’Université de Montréal/Institut du cancer de Montréal, Montréal, Québec, Canada

3. Department of Pathology, Centre hospitalier de l’Université de Montréal, Montréal, Québec, Canada

4. Department of Surgery, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) and Europe Hospitals, Brussels, Belgium

5. Department of Medicine, Université de Montréal, Montreal, QC, Canada

Funder

Université de Montréal Roger Des Groseillers Research Chair in Hepatopancreatobiliary Surgical Oncology

Université de Montréal

Fonds de recherche du Québec - Santé

Institut du Cancer de Montréal

International Hepato-Pancreato-Biliary Association

Ethicon

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2253642

Reference25 articles.

1. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

2. Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection

3. Evolution of Metastases in Space and Time under Immune Selection

4. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

5. Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure